• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804300-18
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/25/2021
Event Type  malfunction  
Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
During inventory clearance of the hospital it was noted that a 3.0x18mm xience skypoint had a different lot number between the manufacturing label and the (b)(6) label of the xience skypoint.The device was not unpacked and not used.The manufacturing label has lot number 0090841 and the (b)(6) label has 0090741.There was no patient involvement and no clinically significant delay.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported labeling problem was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported labeling issue appears to be related to a potential product quality issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.The xience skypoint device is not currently commercially available in the us; however, it is similar to a device sold in the us.
 
Event Description
It was reported that during inventory clearance of the hospital it was noted that a 3.0x18mm xience skypoint had a different lot number between the manufacturing label and the japanese label of the xience skypoint.The device was not unpacked and not used.The manufacturing label has lot number 0090841 and the japanese label has 0090741.There was no patient involvement and no clinically significant delay.No additional information was provided.Based on re-review of this event, this event would not have been reportable because the device marking/labeling issue of lot # does not impact the use of the device and there is no potential for a serious injury.However, since the initial report has already been filed, this event must remain reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11679617
MDR Text Key245825982
Report Number2024168-2021-03221
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233241
UDI-Public08717648233241
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/10/2023
Device Model Number1804300-18
Device Catalogue Number1804300-18
Device Lot Number0090841
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/15/2021
Initial Date Manufacturer Received 03/25/2021
Initial Date FDA Received04/16/2021
Supplement Dates Manufacturer Received05/27/2021
Supplement Dates FDA Received06/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-